Background
==========

Mortality estimates alone are not sufficient to understand the true magnitude and trends of cancer problems and to evaluate the interventions against cancer, in particular preventive programmes \[[@B1]\]. Although cancer is still a fatal disease in many developing countries\[[@B2]\], the disability among cancer survivors should be taken into account since there is a growing evidence that cancer survival in some developing countries are continuously improving \[[@B3],[@B4]\] and, when setting priorities, cancer control interventions are compared with other health interventions which aims at reducing morbidity \[[@B5]\]. For this reason, estimates of both mortality and incidence of cancer by region are essential inputs for setting research and intervention priorities in cancer control policies.

The present study is aimed at estimating the magnitude of global and regional cancer mortality and incidence as a part of detailed analysis of all-cause levels and cause of death distributions for 191 Member States of the World Health Organization (WHO) for the Global Burden of Disease 2000 (GBD 2000) study \[[@B6]\]. GBD 2000 employs a time-based composite measure of disease burden in terms of disability-adjusted life years (DALYs) which consist of years lived with disability (morbidity) and years of life lost (mortality). To estimate the burden from each disease sequelae, detailed information of incidence, duration, and mortality by age, sex and region is required \[[@B5]\]. This study serves as a basis for the future estimation of cancer burden for the GBD 2000.

The GBD 2000 project classified WHO\'s 6 regions into 17 sub regions according to the levels of child and adult mortality (Table [1](#T1){ref-type="table"}). On the basis of available published information on age-, sex-, and site-specific cancer incidence and survival, we developed an algorithm to estimate region-specific overall cancer mortality, and site-specific survival, death distributions, and incidence for the year 2000.

###### 

Global Burden of Disease 2000 (GBD 2000) project: regions and sub regions

  WHO region   Mortality stratum   Sub region   WHO Member States
  ------------ ------------------- ------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  AFRO         D                   AfrD         Algeria, Angola, Benin, Burkina Faso, Cameroon, Cape Verde, Chad, Comoros, Equatorial Guinea, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Madagascar, Mali, Mauritania, Mauritius, Niger, Nigeria, Sao Tome And Principe, Senegal, Seychelles, Sierra Leone, Togo, Djibouti, Somalia, Sudan
  AFRO         E                   AfrE         Botswana, Burundi, Central African Republic, Congo, Côte d\'Ivoire, Democratic Republic Of The Congo, Eritrea, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia, Rwanda, South Africa, Swaziland, Uganda, United Republic of Tanzania, Zambia, Zimbabwe
  AMRO         A                   AmrA         Canada, United States Of America
  AMRO         B                   AmrB         Antigua And Barbuda, Argentina, Bahamas, Barbados, Belize, Brazil, Chile, Colombia, Costa Rica, Dominica, Dominican Republic, El Salvador, Grenada, Guyana, Honduras, Jamaica, Mexico, Panama, Paraguay, Saint Kitts And Nevis, Saint Lucia, Saint Vincent And The Grenadines, Suriname, Trinidad And Tobago, Uruguay, Venezuela Cuba
  AMRO         D                   AmrD         Bolivia, Ecuador, Guatemala, Haiti, Nicaragua, Peru
  EMRO         B                   EmrB         Bahrain, Cyprus, Iran (Islamic Republic Of), Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Oman, Qatar, Saudi Arabia, Syrian Arab Republic, Tunisia, United Arab Emirates
  EMRO         D                   EmrD         Egypt, Iraq, Morocco, Yemen
  EURO         A                   EurA         Andorra, Austria, Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Slovenia, Spain, Sweden, Switzerland, United Kingdom
  EURO         B1                  EurB1        Albania, Bosnia And Herzegovina, Bulgaria, Georgia, Poland, Romania, Slovakia, The Former Yugoslav Republic Of Macedonia, Turkey, Yugoslavia
  EURO         B2                  EurB2        Armenia, Azerbaijan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan
  EURO         C                   EurC         Belarus, Estonia, Hungary, Kazakhstan, Latvia, Lithuania, Republic of Moldova, Russian Federation, Ukraine
  SEARO        B                   SearB        Indonesia, Sri Lanka, Thailand Malaysia, Philippines Brunei Darussalam, Singapore
  SEARO        D                   SearD        Bangladesh, Bhutan, India, Maldives, Nepal Afghanistan, Pakistan
  WPRO         A                   WprA         Australia, Japan, New Zealand
  WPRO         B1                  WprB1        China, Mongolia, Republic Of Korea DPR Korea
  WPRO         B2                  WprB2        Cambodia, Lao People\'s Democratic Republic, Viet Nam Myanmar
  WPRO         B3                  WprB3        Cook Islands, Fiji, Kiribati, Marshall Island s, Micronesia (Federated States Of), Nauru, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu

In the previous paper, we presented the cancer survival model as a key input to estimate the distribution of cancer deaths by site for the regions where mortality data are either scarce or unavailable and tested its performance and validity \[[@B7]\]. In this paper, we present a detailed approach to estimating mortality and incidence of cancer by site and the results of mortality and incidence estimation by site for the year 2000.

Material and Methods
====================

Overview of analysis
--------------------

The Global Burden of Disease 2000 (GBD 2000) study deals with the problem of systemic bias in cause-specific mortality by estimating total mortality for each Member State, starting from an analysis of the overall mortality envelope for each region, in order to ensure that the cause-specific estimates add to the total all cause mortality by age and sex and that there is not systematic over- or under- estimation or double counting of deaths. This regional cause-specific mortality envelope serves as an upper bond of mortality from a certain cause and partly ensures the internal consistency among incidence, prevalence and mortality rates \[[@B6]\]. The approaches to estimating mortality and incidence of cancer by site also follows this process (Figure [1](#F1){ref-type="fig"}).

![Approaches to estimating global and regional cancer mortality and incidence by site for the Global Burden of Disease 2000 (GBD 2000)](1471-2407-2-37-1){#F1}

Firstly, we obtained the age- and sex- specific mortality envelope for all malignancies by region derived from the analysis of country life-tables and cause of death models in each region. Secondly, we estimated the site-specific cancer mortality distributions from vital records or cancer survival models depending on the availability and quality of detailed cause of death data. Cancer sites for which survival was calculated were: mouth and pharynx (ICD-10 C00-C14), oesophagus (C15), stomach (C16), colon and rectum (C18-C21), liver (C22), pancreas (C25), trachea, bronchus and lung (C33-C34), melanoma (C43), female breast (C50), cervix uterine (C53), corpus uteri (C54-55), ovary (C56), prostate (C61), bladder (C67), lymphomas and multiple myeloma (C81-C90, C96), leukaemia (C91-C95), and other malignant neoplasms (balance of ICD-10 C00-C97). The GBD 2000 assigns Kaposi\'s sarcoma and non-Hodgkin lymphomas (NHL) attributable to HIV/AIDS among AIDS sequela and their burden is included separately with HIV/AIDS. Thirdly, the final regional cancer mortality by site is estimated by disaggregating the regional cancer envelope based on the mortality distribution by site. Finally, we applied the incidence-to-mortality rate ratios to back calculate the final cancer incidence estimates by site.

GBD 2000 regional mortality estimates by age, sex, and cause
------------------------------------------------------------

Complete or incomplete vital registration data together with sample registration systems now cover 74% of global mortality in 128 countries. Survey data and indirect demographic techniques provide information on levels of child and adult mortality for the remaining 26% of estimated global mortality. The available sources of mortality data for the WHO sub regions of the GBD 2000 are summarised in Table [1](#T1){ref-type="table"}.

Causes of death for the WHO sub regions and the world have been estimated based on data from national vital registration systems that capture about 17 million deaths annually. In addition, information from sample registration systems, population laboratories and epidemiological analyses of specific conditions have been used to improve estimates of the cause of death patterns \[[@B6],[@B8],[@B9]\]. As a general rule, vital registration data, suitably corrected for ill-defined coding and probable systematic biases in certifying deaths to non-specific vascular, cancer and injury codes were used to estimate the cause of death pattern. The GBD 2000 approach adjusts the cause-specific mortality to include a proportion of deaths coded to ill-defined causes in vital registration data and redistributes these deaths pro-rata among broader communicable and non-communicable causes.

Cause of death data have been carefully analysed to take into account incomplete coverage of vital registration in countries and the likely differences in cause of death patterns that would be expected in the uncovered and often poorer sub-populations \[[@B10]\]. For countries lacking sufficient vital registration data, cause of death models were used to firstly estimate the maximum likelihood distribution of deaths across the broad categories of communicable, non-communicable and injuries, based on estimated total mortality rates and income \[[@B8]\]. A regional model pattern of specific causes of death was then constructed based on local vital registration and verbal autopsy data, and this proportionate distribution was then applied within each broad cause group. Finally, the resulting estimates were then adjusted based on other epidemiological evidence from specific disease studies. Methods used to estimate global all-cause and cause-specific mortality from these data are described elsewhere \[[@B6]\].

In the GBD 1990 \[[@B5]\], deaths coded to ICD-9 195--199 (i.e., malignant neoplasm of other and unspecified sites including those whose point of origin cannot be determined, secondary and unspecified neoplasm) were redistributed pro-rata across all malignant neoplasm categories within each age-sex group, so that the category \'Other malignant neoplasms\' includes only malignant neoplasms of other specified sites. Reviews of the cancer registry and methods of diagnosis suggest that four sites (month and pharynx, liver, breast and cervix uteri) where there did not appear to be any significant mis-coding of cancer deaths, since these can be diagnosed clinically without any further diagnostic tests even in developing regions \[[@B11]\]. Accordingly, the cancer garbage code redistribution algorithm was revised for the GBD 2000 to redistribute cancer deaths in ICD C76-C80 pro-rata across the sites other than the four sites above.

Estimation of cancer mortality and incidence
--------------------------------------------

Given the regional cancer mortality envelope by age and sex, the site-specific distributions of cancer mortality are necessary to disagreggate the estimated total cancer deaths by age and sex for each region. The approaches to estimating mortality distributions were different depending on the availability and quality of data on detailed causes of death.

Direct estimates of the site-specific distributions of cancer mortality were possible for the regions where established vital registration records with high coverage and ICD-coding are available, including countries in the A sub regions (AmrA, EurA and WprA) and countries in AmrB, EurB1, EurB2 and EurC \[[@B6]\]. For the other regions of the world (AfrD, AfrE, AmrD, EmrB, EmrD, SearB, SearD, WprB1, WprB2 and WprB3 sub regions), a site-specific model for relative interval survival adjusted for each region was developed and applied to the regional incidence estimated by International Agency for Research on Cancer (IARC) to calculate the mortality distribution by site for the year 2000 \[[@B7],[@B12]\]. The region-specific incidence estimates of the Globocan 2000 was adjusted to ensure the consistency with the GBD 2000 definitions \[[@B7]\]. Our survival model and adjusted incidence estimates of the Globocan 2000 were primarily used to estimate the distribution, but not the magnitude, of cancer by site, sex, and age group.

The final site-specific cancer mortality was then estimated by multiplying age- and sex- specific regional cancer mortality envelope by estimated cancer mortality distribution by site. The cancer survival model is flexible enough to yield the survival estimates of various age, years and period as well as mean duration of time of cancer by site \[[@B7]\]. We estimated incidence-to-mortality rate ratios at each age group form the survival model and, by using the final cancer mortality, applied the ratios to back calculate the final incidence by age and sex for each cancer site in all regions of the world for the year 2000.

Results
=======

Cancer mortality by region
--------------------------

The GBD 2000 classifies the cause of deaths into three broad categories: communicable disease, non-communicable disease, and injuries. In 2000, approximately 56 million deaths occurred world wide and non-communicable disease accounted for 58% of total number of deaths, followed by communicable disease (33%) and injuries (9%) (Figure [2](#F2){ref-type="fig"}). Cancer was estimated to account for over 7 million deaths (13% of total mortality and 22% of non-communicable disease mortality) world wide in 2000, only preceded by cardiovascular diseases (29 % of total) and infectious and parasitic diseases (19%). Depending on the extent of health transition, cancer mortality as a proportion of total mortality differed substantially by region, from less than 5% in AfrE to approximately 30% in WprA sub region.

![Regional distribution of mortality by cause, 2000](1471-2407-2-37-2){#F2}

Tables [2](#T2){ref-type="table"},[3](#T3){ref-type="table"},[4](#T4){ref-type="table"},[5](#T5){ref-type="table"} show the regional estimates of total number of deaths and age-specific mortality rates of all cancers for the GBD 2000. More than 60% of cancer deaths occurred in developing regions, particularly in SearD (mainly India) and WprB1(mainly China) sub regions due to their large population size. On average global cancer mortality rates among males and females were 128.2 and 104.6 per 100,000, respectively. Not surprisingly crude mortality rates from all cancers vary significantly and are much higher in developed regions (AmrA, EurA, and WprA). However, since age-specific mortality rate is generally higher in developing regions, regional mortality rates, age-standardised to the world population, showed less variations compared to crude mortality rates and higher mortality rates were observed in regions such as AfrD, AfrE, AmrB, EurC, and WprB (Figure [3](#F3){ref-type="fig"}).

![Age-standardised mortality rate from all cancers by region, 2000](1471-2407-2-37-3){#F3}

###### 

Mortality data sources (number of Member States with recent deaths coverage) by WHO sub region for the GBD2000

  Subregion   **Category I**: Complete vital statistics (95%+ coverage)   **Category II**: Incomplete vital statistics   **Category III**: Sample registration and surveillance systems   **Category IV**: Child mortality estimated from surveys and censuses   **Category V**: No recent data on child or adult mortality   Number of countries
  ----------- ----------------------------------------------------------- ---------------------------------------------- ---------------------------------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------ ---------------------
  AfrD        2                                                           2                                              0                                                                19                                                                     3                                                            26
  AfrE        0                                                           2                                              1                                                                14                                                                     3                                                            20
  AmrA        3                                                           0                                              0                                                                0                                                                      0                                                            3
  AmrB        17                                                          9                                              0                                                                0                                                                      0                                                            26
  AmrD        0                                                           4                                              0                                                                2                                                                      0                                                            6
  EmrB        4                                                           3                                              0                                                                6                                                                      0                                                            13
  EmrD        0                                                           2                                              0                                                                5                                                                      2                                                            9
  EurA        26                                                          0                                              0                                                                0                                                                      0                                                            26
  EurB        7                                                           9                                              0                                                                0                                                                      0                                                            16
  EurC        8                                                           1                                              0                                                                0                                                                      0                                                            9
  SearB       1                                                           1                                              0                                                                1                                                                      0                                                            3
  SearD       0                                                           1                                              2                                                                3                                                                      1                                                            7
  WprA        4                                                           1                                              0                                                                0                                                                      0                                                            5
  WprB        3                                                           12                                             1                                                                6                                                                      0                                                            22
                                                                                                                                                                                                                                                                                                                              
  World       75                                                          47                                             4                                                                56                                                                     9                                                            191

###### 

Estimated global and regional number of total cancer deaths (thousands) and mortality rate (per 100,000) by age, both sexes, 2000

  Region                                    Age-group                                                                  
  ----------------------------------------- ----------- ------ ------- ------- --------- --------- --------- --------- ---------
  Number of deaths (000s)                                                                                              
  World                                     46.0        49.4   141.3   462.1   1,503.0   1,852.4   1,901.0   1,078.7   7,033.9
  AfrD                                      5.0         2.5    10.7    26.3    59.2      70.0      66.5      31.5      271.6
  AfrE                                      4.9         2.6    15.2    33.1    65.0      76.4      72.1      31.5      300.8
  AmrA                                      0.6         1.2    3.9     23.1    102.4     132.3     194.5     168.1     626.2
  AmrB                                      3.2         4.4    10.7    31.7    86.4      94.3      103.5     66.6      400.8
  AmrD                                      1.0         1.4    2.7     6.4     14.8      16.0      18.9      11.5      72.9
  EmrB                                      1.2         2.0    3.8     8.0     19.2      18.2      17.8      7.7       77.8
  EmrD                                      1.9         2.5    4.3     10.6    17.8      15.1      13.2      4.3       69.7
  EurA                                      0.7         1.5    5.3     31.3    154.1     238.2     350.9     279.8     1,061.7
  EurB1                                     0.7         1.1    3.9     16.6    59.3      76.6      69.8      26.5      254.5
  EurB2                                     0.2         0.6    1.4     4.3     7.9       10.9      7.5       1.9       34.8
  EurC                                      0.8         1.7    5.8     28.4    114.2     162.1     146.1     44.5      503.7
  SearB                                     2.9         4.0    7.9     30.9    90.0      79.8      59.1      25.9      300.6
  SearD                                     12.9        11.9   32.7    65.1    189.0     262.1     192.2     109.2     875.1
  WprA                                      0.2         0.4    1.6     7.7     49.6      77.6      104.2     90.4      331.6
  WprB1                                     8.9         10.6   28.5    128.2   451.6     503.1     467.5     165.6     1,764.0
  WprB2                                     0.9         1.0    3.0     9.5     21.4      18.9      16.7      13.3      84.8
  WprB3                                     0.0         0.1    0.2     0.6     1.2       0.7       0.4       0.2       3.4
                                                                                                                       
  Age-specific mortality rate per 100,000                                                                              
  World                                     7.6         4.1    9.0     36.3    186.8     548.2     965.1     1,702.1   116.5
  AfrD                                      9.1         2.8    11.6    49.5    210.0     667.6     1,386.4   2,799.0   81.4
  AfrE                                      8.5         2.7    16.3    63.6    243.8     798.9     1,612.8   2,932.2   89.1
  AmrA                                      2.9         2.6    6.3     31.5    178.2     581.8     1,074.1   1,901.0   203.1
  AmrB                                      7.0         4.9    8.6     34.1    159.9     463.9     895.3     1,773.8   90.7
  AmrD                                      10.7        8.2    13.3    51.0    211.0     593.4     1,354.4   2,827.8   102.3
  EmrB                                      7.3         5.7    9.1     31.5    144.0     374.6     688.6     1,182.8   55.8
  EmrD                                      10.2        7.5    11.0    41.5    129.5     305.6     540.6     716.3     50.5
  EurA                                      3.2         3.1    6.6     33.1    196.8     570.4     1,109.9   2,089.7   259.6
  EurB1                                     5.7         4.2    9.0     47.1    226.3     602.5     874.0     1,325.3   153.5
  EurB2                                     3.7         4.8    10.0    41.5    172.8     450.4     584.6     550.4     68.4
  EurC                                      6.7         5.1    10.4    51.3    266.1     656.0     911.4     1,012.8   205.4
  SearB                                     7.1         5.0    7.0     36.7    192.9     442.1     679.3     1,109.6   76.2
  SearD                                     8.0         3.9    8.8     24.9    124.6     448.9     681.4     1,499.2   64.9
  WprA                                      2.4         2.3    5.1     25.9    153.3     471.8     927.3     1,907.7   222.6
  WprB1                                     8.6         4.5    8.4     38.1    218.2     617.6     1,080.7   1,435.2   130.0
  WprB2                                     5.9         3.3    7.2     31.7    152.4     312.2     525.6     1,540.4   59.7
  WprB3                                     4.3         4.3    8.2     47.8    173.4     280.3     378.4     1,162.9   49.1

###### 

Estimated global and regional number of total cancer deaths (thousands) and mortality rate (per 100,000) by age, males, 2000

  Region                                    Age-group                                                               
  ----------------------------------------- ----------- ------ ------ ------- ------- --------- --------- --------- ---------
  Number of deaths (000s)                                                                                           
  World                                     22.6        27.4   79.9   228.3   844.8   1,121.7   1,074.6   502.6     3,901.9
  AfrD                                      2.1         1.3    6.2    14.3    29.2    34.2      34.8      17.1      139.3
  AfrE                                      2.6         1.5    9.6    20.3    33.3    36.2      36.1      17.0      156.8
  AmrA                                      0.3         0.6    2.3    10.5    54.0    74.5      105.8     77.1      325.1
  AmrB                                      1.7         2.5    6.0    12.4    41.4    51.7      57.6      33.9      207.1
  AmrD                                      0.4         0.8    1.4    2.2     5.4     7.5       9.6       5.9       33.3
  EmrB                                      0.7         1.2    1.9    3.0     10.0    11.6      11.6      4.8       44.9
  EmrD                                      1.2         1.5    2.4    5.1     9.0     8.8       7.6       2.7       38.2
  EurA                                      0.4         0.9    3.2    15.2    90.1    151.1     205.8     127.8     594.3
  EurB1                                     0.4         0.7    2.1    8.7     37.2    49.5      39.9      12.1      150.5
  EurB2                                     0.1         0.3    0.8    2.0     4.4     6.6       3.9       0.7       18.9
  EurC                                      0.4         1.0    3.3    13.8    70.1    101.2     73.5      15.9      279.2
  SearB                                     1.5         2.0    4.2    11.8    45.4    48.4      35.7      12.8      161.8
  SearD                                     6.0         6.0    15.5   31.0    88.4    148.3     106.4     48.7      450.1
  WprA                                      0.1         0.2    0.8    3.4     29.2    52.8      67.0      44.9      198.5
  WprB1                                     4.1         6.2    18.7   69.7    285.7   327.5     268.6     73.8      1,054.3
  WprB2                                     0.5         0.6    1.6    4.6     11.4    11.7      10.3      7.2       47.9
  WprB3                                     0.0         0.0    0.1    0.2     0.6     0.4       0.2       0.1       1.6
                                                                                                                    
  Age-specific mortality rate per 100,000                                                                           
  World                                     7.3         4.5    10.0   35.3    209.6   694.5     1,264.5   2,095.6   128.2
  AfrD                                      7.6         2.9    13.5   54.6    214.0   697.7     1,607.5   3,446.7   83.9
  AfrE                                      9.0         3.3    20.6   78.4    258.1   824.4     1,866.5   4,078.5   93.5
  AmrA                                      3.0         2.8    7.2    28.4    190.0   689.9     1,353.3   2,286.9   213.1
  AmrB                                      7.4         5.4    9.6    27.1    158.5   546.5     1,139.1   2,145.2   94.5
  AmrD                                      9.0         8.9    13.5   36.2    158.0   583.7     1,505.9   3,264.8   93.6
  EmrB                                      8.9         6.6    9.1    22.2    137.7   461.9     904.8     1,444.8   62.1
  EmrD                                      12.9        8.9    11.8   39.2    134.5   385.5     704.1     1,014.3   54.8
  EurA                                      3.4         3.6    7.7    31.7    230.9   762.6     1,576.8   2,711.7   295.6
  EurB1                                     6.3         5.0    9.7    48.8    288.5   847.1     1,225.6   1,657.4   183.0
  EurB2                                     4.8         5.6    10.9   38.8    197.1   598.0     772.0     676.4     75.0
  EurC                                      7.0         5.6    11.6   50.4    351.0   1,001.0   1,453.4   1,541.1   242.3
  SearB                                     7.0         4.9    7.3    28.0    199.0   569.2     905.5     1,264.7   82.0
  SearD                                     7.1         3.8    8.0    22.7    113.7   516.9     792.8     1,419.2   64.8
  WprA                                      2.9         2.9    5.4    22.9    181.1   668.2     1,387.3   2,603.3   270.5
  WprB1                                     7.5         5.1    10.6   40.3    267.2   796.0     1,372.3   1,729.7   151.1
  WprB2                                     5.9         3.8    7.6    31.3    175.1   431.4     784.9     2,303.2   68.1
  WprB3                                     5.1         5.5    7.0    29.3    162.4   329.5     476.3     1,404.1   46.7

###### 

Estimated global and regional number of total cancer deaths (thousands) and mortality rate (per 100,000) by age, females, 2000

  Region                                    Age-group                                                             
  ----------------------------------------- ----------- ------ ------ ------- ------- ------- --------- --------- ---------
  Number of deaths (000s)                                                                                         
  World                                     23.4        22.0   61.4   233.8   658.2   730.6   826.4     576.2     3,132.0
  AfrD                                      2.9         1.2    4.4    12.0    30.0    35.8    31.7      14.4      132.3
  AfrE                                      2.3         1.0    5.6    12.8    31.7    40.2    35.9      14.4      144.0
  AmrA                                      0.3         0.5    1.6    12.6    48.4    57.8    88.7      91.1      301.1
  AmrB                                      1.5         2.0    4.7    19.3    45.0    42.6    45.9      32.7      193.8
  AmrD                                      0.6         0.6    1.4    4.2     9.4     8.5     9.3       5.6       39.6
  EmrB                                      0.4         0.8    1.8    5.0     9.2     6.6     6.2       2.9       32.9
  EmrD                                      0.7         1.0    1.9    5.5     8.8     6.4     5.6       1.6       31.4
  EurA                                      0.3         0.6    2.1    16.2    64.0    87.1    145.1     152.0     467.4
  EurB1                                     0.3         0.4    1.8    7.9     22.1    27.1    29.9      14.4      104.0
  EurB2                                     0.1         0.2    0.6    2.3     3.6     4.3     3.6       1.1       15.9
  EurC                                      0.4         0.7    2.5    14.6    44.1    60.9    72.6      28.7      224.5
  SearB                                     1.5         2.0    3.7    19.1    44.6    31.4    23.4      13.1      138.8
  SearD                                     6.9         5.9    17.2   34.2    100.6   113.8   85.8      60.5      425.0
  WprA                                      0.1         0.1    0.7    4.3     20.4    24.9    37.2      45.5      133.1
  WprB1                                     4.8         4.3    9.8    58.5    165.9   175.7   198.8     91.8      709.7
  WprB2                                     0.4         0.4    1.4    5.0     9.9     7.2     6.4       6.2       36.9
  WprB3                                     0.0         0.0    0.1    0.4     0.6     0.3     0.2       0.1       1.7
                                                                                                                  
  Age-specific mortality rate per 100,000                                                                         
  World                                     8.0         3.8    8.0    37.3    163.9   414.3   737.9     1,462.6   104.6
  AfrD                                      10.6        2.6    9.6    44.6    206.1   641.3   1,204.5   2,286.7   78.9
  AfrE                                      8.1         2.2    12.0   48.9    230.4   777.2   1,418.8   2,202.6   84.8
  AmrA                                      2.7         2.4    5.3    34.7    166.6   484.1   862.1     1,663.3   193.4
  AmrB                                      6.6         4.4    7.7    40.9    161.3   392.0   705.7     1,504.1   86.9
  AmrD                                      12.5        7.5    13.2   65.1    260.9   602.3   1,226.6   2,479.1   110.8
  EmrB                                      5.5         4.8    9.2    42.1    151.7   280.7   474.5     909.5     49.0
  EmrD                                      7.4         5.9    10.1   43.8    124.7   237.8   411.1     481.1     46.1
  EurA                                      2.9         2.6    5.4    34.6    162.9   397.0   781.7     1,751.8   224.7
  EurB1                                     5.0         3.4    8.3    45.3    166.0   394.8   632.1     1,134.8   124.4
  EurB2                                     2.5         4.1    9.1    44.1    150.2   326.0   463.3     491.3     61.9
  EurC                                      6.4         4.5    9.1    52.2    192.2   417.0   661.6     851.5     172.7
  SearB                                     7.3         5.1    6.6    45.4    187.2   329.0   491.8     991.1     70.5
  SearD                                     8.8         4.0    9.7    27.2    136.1   383.2   580.4     1,570.4   65.1
  WprA                                      2.0         1.7    4.7    29.0    125.6   290.5   580.5     1,509.3   176.2
  WprB1                                     9.9         3.9    6.0    35.7    165.9   435.6   839.7     1,262.3   107.6
  WprB2                                     6.0         2.9    6.8    32.1    132.6   215.4   342.3     1,113.7   51.5
  WprB3                                     3.5         3.0    9.5    68.4    184.5   233.3   294.1     960.7     51.7

Cancer mortality envelope was disaggregated by applying the distribution of cancer mortality by site estimated from both the detailed analysis of vital records and the use of survival model and incidence data from the International Agency for Research on Cancer (IARC). Tables [6](#T6){ref-type="table"} and [7](#T7){ref-type="table"} show the estimated global and regional numbers of deaths and age-standardised mortality rates by sex for 17 cancer sites. Generally higher mortality rates were observed in developing regions except cancers of lung and pancreas which are more prevalent in developed regions and highly fatal.

###### 

Estimated global and regional number of cancer deaths and age-standardised mortality rate by site, males, 2000

                                                            WHO sub region                                                                                                                
  ------------------------------------------------- ------- ---------------- ------ ------- ------ ------ ------ ------ ------- ------ ------ ------ ------ ------- ------ ------- ------ ------
  **Number of deaths (000s)**                                                                                                                                                             
  Mouth and oropharynx cancers                      222.4   10.7             14.3   6.6     8.5    0.7    2.0    1.5    19.2    6.0    0.8    14.7   13.1   88.9    4.1    25.5    5.4    0.4
  Oesophagus cancer                                 273.6   4.9              13.8   11.6    10.5   0.7    1.8    0.7    21.4    3.4    1.7    10.0   3.3    41.9    9.4    135.7   2.9    0.0
  Stomach cancer                                    512.0   12.0             9.8    10.0    25.8   7.6    7.5    2.3    38.9    14.9   3.5    42.2   7.1    28.1    34.3   261.1   6.8    0.1
  Colon and rectum cancers                          311.8   7.4              8.8    36.1    14.4   1.6    2.2    2.3    72.1    14.3   1.0    28.7   13.9   19.6    23.1   63.3    2.9    0.1
  Liver cancer                                      414.9   20.6             23.5   8.7     9.3    2.8    3.0    2.3    25.3    5.8    0.7    7.8    25.9   17.3    23.8   231.5   6.3    0.2
  Pancreas cancer                                   117.0   1.5              2.7    16.0    7.9    1.1    0.9    1.0    26.7    5.8    1.0    11.2   3.5    7.6     11.2   18.4    0.5    0.0
  Trachea, bronchus, lung cancers                   877.3   7.0              9.4    101.4   36.1   1.6    8.7    7.1    158.0   46.6   3.8    83.6   40.8   102.7   43.2   214.6   12.4   0.3
  Melanoma of the skin                              35.1    2.4              2.2    7.7     3.3    0.6    0.2    0.1    8.3     2.0    0.2    2.5    0.7    1.4     1.7    1.6     0.1    0.0
  Breast cancer                                     2.6     0.0              0.0    0.5     0.3    0.0    0.0    0.0    0.9     0.2    0.1    0.5    0.0    0.0     0.1    0.0     0.0    0.0
  Cervix uteri cancer                               0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Corpus uteri cancer                               0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Ovary cancer                                      0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Prostate cancer                                   263.6   26.0             19.2   39.6    30.4   5.8    2.1    1.7    70.2    9.4    0.5    13.3   8.1    19.8    10.4   6.1     0.9    0.0
  Bladder cancer                                    123.9   6.9              4.3    10.3    4.9    0.5    2.6    7.7    27.1    7.1    0.7    10.4   4.4    15.9    4.1    15.9    1.0    0.0
  Lymphomas, multiple myeloma                       168.6   15.9             13.7   23.1    9.6    2.1    4.1    3.6    27.6    5.6    0.9    5.4    9.6    26.1    7.8    11.2    2.0    0.1
  Leukaemia                                         145.3   5.2              6.9    14.5    9.6    2.0    2.3    3.7    20.0    5.4    0.8    7.8    7.6    21.0    4.9    31.9    1.7    0.1
  Other malignant neoplasms                         425.2   18.7             25.6   39.0    36.5   6.0    7.5    4.2    79.1    24.0   3.2    41.3   16.6   60.5    20.4   37.4    5.0    0.2
                                                                                                                                                                                          
  **Age-standardized mortality rate per 100,000**                                                                                                                                         
  Mouth and oropharynx cancers                      7.3     11.7             16.6   2.8     4.5    2.8    4.0    3.1    5.5     5.9    4.0    9.0    8.0    16.7    2.8    3.4     10.7   18.4
  Oesophagus cancer                                 9.0     5.5              16.4   4.8     5.6    3.0    3.6    1.6    5.6     3.2    9.0    5.9    2.1    7.9     6.1    18.3    6.1    1.9
  Stomach cancer                                    16.8    13.5             11.7   3.9     13.7   31.5   15.1   4.9    9.3     14.2   18.7   25.1   4.5    5.3     21.5   35.5    14.2   3.3
  Colon and rectum cancers                          10.2    8.1              11.0   13.7    7.6    6.5    4.2    4.8    17.0    13.6   5.2    17.0   8.9    3.7     14.6   8.7     6.0    4.1
  Liver cancer                                      13.6    20.9             25.6   3.6     4.9    11.1   6.2    5.0    6.2     5.6    3.6    4.6    15.9   3.1     15.7   30.5    12.2   10.1
  Pancreas cancer                                   3.8     1.6              3.4    6.3     4.2    4.7    1.8    2.2    6.6     5.6    5.3    6.7    2.2    1.5     7.1    2.5     1.0    0.2
  Trachea, bronchus, lung cancers                   28.8    7.9              11.5   40.1    19.3   6.5    17.7   15.9   39.5    44.2   19.7   48.9   26.0   19.4    26.3   29.1    25.1   13.8
  Melanoma of the skin                              1.2     2.7              2.6    3.2     1.7    2.5    0.4    0.2    2.2     2.0    1.1    1.6    0.5    0.3     1.1    0.2     0.2    2.4
  Breast cancer                                     0.1     0.0              0.0    0.2     0.2    0.1    0.0    0.0    0.2     0.2    0.3    0.3    0.0    0.0     0.1    0.0     0.0    0.0
  Cervix uteri cancer                               0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Corpus uteri cancer                               0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Ovary cancer                                      0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Prostate cancer                                   8.7     33.3             27.9   12.7    16.2   24.9   4.5    4.3    14.3    8.8    2.9    7.8    5.6    4.1     5.7    0.9     1.9    1.5
  Bladder cancer                                    4.1     8.4              5.8    3.6     2.6    2.2    5.6    17.7   6.0     6.7    4.0    6.1    2.9    3.1     2.3    2.3     2.3    0.8
  Lymphomas, multiple myeloma                       5.5     15.1             13.5   9.2     4.9    8.3    7.3    6.3    7.1     5.7    4.4    3.5    5.8    4.6     5.1    1.5     3.6    5.5
  Leukaemia                                         4.8     4.9              6.7    5.9     4.7    6.5    3.7    5.9    5.4     5.7    3.4    5.3    4.2    3.3     3.9    4.6     2.6    2.6
  Other malignant neoplasms                         14.0    20.2             31.0   16.6    18.9   23.0   14.6   8.4    21.4    23.6   16.0   26.1   10.2   11.3    13.6   5.2     10.3   8.5

###### 

Estimated global and regional number of cancer deaths and age-standardised mortality rate by site, females, 2000

                                                            WHO sub region                                                                                                               
  ------------------------------------------------- ------- ---------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------- ------ ------- ------ ------- ------ ------
  **Number of deaths (000s)**                                                                                                                                                            
  Mouth and oropharynx cancers                      97.2    5.3              7.1    3.3    2.7    0.5    1.1    0.6    5.7    1.5    0.3    2.9     5.5    42.7    1.7    13.6    2.6    0.2
  Oesophagus cancer                                 157.6   4.0              6.8    3.7    3.8    0.3    1.5    0.5    7.8    1.0    1.3    3.5     2.3    33.6    2.0    83.6    2.0    0.0
  Stomach cancer                                    324.2   8.9              7.2    7.0    16.5   7.1    3.7    1.6    27.9   8.6    2.2    30.6    5.5    16.1    19.0   157.7   4.6    0.1
  Colon and rectum cancers                          295.5   5.6              5.3    37.2   16.1   2.1    2.2    1.7    69.7   11.8   1.1    33.61   3.6    14.01   9.4    59.72   2.2    0.1
  Liver cancer                                      191.0   11.0             9.8    5.3    9.1    3.2    1.2    1.1    13.3   3.8    0.5    5.6     10.6   10.4    10.5   93.5    2.2    0.2
  Pancreas cancer                                   105.6   1.5              2.5    16.9   8.7    1.2    0.7    0.6    26.9   4.6    0.7    9.8     3.3    5.2     9.4    13.0    0.5    0.0
  Trachea, bronchus, lung cancers                   323.8   2.9              4.5    70.5   14.9   0.9    2.5    2.3    49.2   9.8    1.1    16.2    7.5    23.2    16.9   97.6    3.7    0.2
  Melanoma of the skin                              30.1    2.4              3.0    4.3    2.7    0.6    0.2    0.1    7.2    1.9    0.2    3.0     1.0    1.0     1.1    1.2     0.1    0.0
  Breast cancer                                     466.3   18.6             23.0   53.3   30.7   4.0    5.1    7.0    91.8   18.5   2.5    39.4    29.0   67.0    12.4   57.5    6.3    0.2
  Cervix uteri cancer                               259.6   24.1             36.8   5.3    19.3   4.6    3.5    2.6    8.3    6.3    1.0    11.7    15.4   86.2    2.6    26.1    5.4    0.3
  Corpus uteri cancer                               72.9    1.4              1.7    8.2    10.4   3.5    0.4    0.3    16.0   4.3    0.8    11.0    4.0    3.2     3.3    4.1     0.2    0.0
  Ovary cancer                                      128.6   3.9              6.7    15.5   7.0    1.1    0.9    0.9    25.7   5.7    0.6    12.9    8.7    18.5    4.9    13.8    1.6    0.1
  Prostate cancer                                   0.0     0.0              0.0    0.0    0.0    0.0    0.0    0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0     0.0    0.0
  Bladder cancer                                    53.5    2.3              2.0    4.9    2.1    0.3    0.5    2.0    10.5   1.7    0.2    2.8     1.4    14.2    1.9    6.3     0.6    0.0
  Lymphomas, multiple myeloma                       163.7   6.6              5.2    21.7   8.0    1.6    2.8    2.4    27.4   4.3    0.5    4.8     6.1    54.8    6.2    9.4     1.8    0.1
  Leukaemia                                         114.7   4.4              4.9    12.0   8.4    1.9    1.7    2.5    17.2   3.8    0.7    7.2     7.2    14.7    3.6    23.1    1.4    0.1
  Other malignant neoplasms                         344.5   29.4             14.8   32.0   33.2   6.9    5.1    5.1    63.0   16.4   2.4    29.6    15.5   19.9    18.3   49.5    3.4    0.2
                                                                                                                                                                                         
  **Age-standardized mortality rate per 100,000**                                                                                                                                        
  Mouth and oropharynx cancers                      3.2     6.6              8.8    1.3    1.5    2.2    2.5    1.3    1.4    1.4    1.4    1.3     3.7    9.9     1.0    2.0     4.9    10.8
  Oesophagus cancer                                 5.3     5.0              8.8    1.3    2.1    1.4    3.8    1.1    1.6    0.9    6.1    1.4     1.6    7.7     1.2    12.7    3.8    1.7
  Stomach cancer                                    10.8    11.3             9.2    2.5    9.1    32.2   9.0    3.6    5.8    7.9    10.6   13.0    3.7    3.8     11.5   24.1    8.7    2.6
  Colon and rectum cancers                          9.9     7.0              7.0    13.0   8.9    9.4    5.6    3.7    14.4   10.7   5.3    13.9    9.3    3.3     11.6   9.1     4.2    2.6
  Liver cancer                                      6.4     12.4             11.5   2.0    5.0    13.9   3.0    2.4    2.9    3.4    2.2    2.4     7.1    2.1     6.2    13.9    3.9    6.9
  Pancreas cancer                                   3.5     1.7              3.4    6.1    4.8    5.6    1.7    1.5    5.7    4.1    3.4    4.1     2.3    1.2     5.5    2.0     0.9    0.3
  Trachea, bronchus, lung cancers                   10.8    3.2              5.3    27.4   8.0    4.0    6.0    5.2    11.6   9.0    5.1    6.9     4.9    4.9     10.1   14.5    6.8    7.7
  Melanoma of the skin                              1.0     3.1              4.1    1.7    1.5    2.6    0.4    0.3    1.7    1.8    1.0    1.5     0.7    0.2     0.7    0.2     0.1    1.5
  Breast cancer                                     15.6    21.4             27.7   21.1   16.0   16.1   12.2   14.4   22.8   17.4   12.0   18.7    17.6   14.5    9.4    8.1     11.3   12.0
  Cervix uteri cancer                               8.7     27.4             43.8   2.4    9.8    18.7   8.7    5.5    2.3    6.1    4.7    5.9     9.3    18.0    2.0    3.9     9.7    15.5
  Corpus uteri cancer                               2.4     1.9              2.3    3.1    5.5    1.5    1.0    0.8    3.5    3.9    3.8    4.7     2.6    0.8     2.1    0.6     0.4    1.2
  Ovary cancer                                      4.3     4.3              8.1    6.1    3.7    4.4    2.2    1.8    6.3    5.3    3.0    6.0     5.3    4.1     3.5    2.0     2.9    3.2
  Prostate cancer                                   0.0     0.0              0.0    0.0    0.0    0.0    0.0    0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0     0.0    0.0
  Bladder cancer                                    1.8     2.9              2.6    1.6    1.2    1.2    1.4    4.6    2.0    1.5    0.9    1.1     1.1    3.1     1.0    1.0     1.1    0.2
  Lymphomas, multiple myeloma                       5.5     6.7              5.6    7.9    4.2    6.5    6.3    4.8    6.1    4.1    2.4    2.3     3.9    11.7    3.8    1.4     3.0    3.1
  Leukaemia                                         3.8     4.7              5.1    4.6    4.1    6.5    3.1    4.3    4.1    3.8    2.8    3.8     4.1    2.6     2.7    3.6     2.1    2.2
  Other malignant neoplasms                         11.5    34.3             18.0   12.5   17.6   28.6   12.5   10.9   14.6   15.3   11.0   14.1    10.1   4.9     11.0   7.7     6.3    8.2

Tables [8](#T8){ref-type="table"} and [9](#T9){ref-type="table"} represent the ranking of the number of deaths by cancer site in the world and three selected sub regions: a high child and adult mortality/low income region (AfrE), a very low child and adult mortality/high income region (EurA), and a low child and adult mortality/middle income region (SearB). Lung cancer was the leading cause of cancer deaths in the world, accounting for 17% of total cancer mortality, followed by cancers of stomach (12% of total), liver (9%), colon and rectum (9%), and breast (7%). In males, lung, stomach, and liver cancers were the three most common cause of cancer deaths. The leading cause of cancer deaths among females was breast but lung cancer was already the second largest cause of cancer deaths.

###### 

Ranking of the global cancer deaths by site, 2000

  site                          Number of death (000s)   Proportion of total (%)
  ----------------------------- ------------------------ -------------------------
  **Both sexes**                                         
  Trachea, bronchus, and lung   1211.5                   17.2
  Stomach                       835.1                    11.9
  Liver                         611.4                    8.7
  Colon and rectum              608.0                    8.6
  Breast                        473.8                    6.7
  Oesophagus                    430.4                    6.1
  Lymphomas and myeloma         329.9                    4.7
  Mouth and oropharynx          320.0                    4.5
  Prostate                      264.0                    3.8
  Leukaemia                     263.8                    3.8
  Cervix uteri                  254.2                    3.6
  Pancreas                      222.3                    3.2
  Bladder                       179.4                    2.6
  Ovary                         130.1                    1.8
  Corpus uteri                  73.5                     1.0
  Melanoma of the skin          65.3                     0.9
                                                         
  **Males**                                              
  Trachea, bronchus, and lung   877.2                    22.5
  Stomach                       511.3                    13.1
  Liver                         419.4                    10.7
  Colon and rectum              312.3                    8.0
  Oesophagus                    272.8                    7.0
  Prostate                      264.0                    6.8
  Mouth and oropharynx          222.0                    5.7
  Lymphomas and myeloma         169.6                    4.3
  Leukaemia                     145.4                    3.7
  Bladder                       126.1                    3.2
  Pancreas                      116.8                    3.0
  Melanoma of the skin          35.0                     0.9
                                                         
  **Females**                                            
  Breast                        471.2                    15.0
  Trachea, bronchus, and lung   334.2                    10.7
  Stomach                       323.7                    10.3
  Colon and rectum              295.7                    9.4
  Cervix uteri                  254.2                    8.1
  Liver                         192.1                    6.1
  Lymphomas and myeloma         160.2                    5.1
  Oesophagus                    157.6                    5.0
  Ovary                         130.1                    4.2
  Leukaemia                     118.4                    3.8
  Pancreas                      105.5                    3.4
  Mouth and oropharynx          98.0                     3.1
  Corpus uteri                  73.5                     2.3
  Bladder                       53.4                     1.7
  Melanoma of the skin          30.3                     1.0

###### 

Ranking of selected regional cancer deaths by site, 2000

  WHO sub region                                                                                                                                                                                                                                                            
  --------------------------------------- ------------------------------------------- --------------------------------------- ----------------------------- ------------------------ ------------------------------- ----------------------------- ------------------------ -------------------------------
  AfrE (high child and adult mortality)   EurA (very low child and adult mortality)   SearB (low child and adult mortality)                                                                                                                                                 
                                                                                                                                                                                                                                                                            
  site                                    Number of death (000s)                      Proportion of total (%)                 site                          Number of death (000s)   Proportion death of total (%)   site                          Number of death (000s)   Proportion death of total (%)
                                                                                                                                                                                                                                                                            
  Both sexes                                                                                                                                                                                                                                                                
  Cervix uteri                            37.3                                        12.4                                    Trachea, bronchus, and lung   207.1                    19.5                            Trachea, bronchus, and lung   48.3                     16.1
  Liver                                   35.3                                        11.7                                    Colon and rectum              141.6                    13.3                            Liver                         39.4                     13.1
  Breast                                  23.8                                        7.9                                     Breast                        92.7                     8.7                             Breast                        29.4                     9.8
  Mouth and oropharynx                    21.6                                        7.2                                     Prostate                      70.1                     6.6                             Colon and rectum              28.5                     9.5
  Oesophagus                              20.7                                        6.9                                     Stomach                       66.7                     6.3                             Mouth and oropharynx          19.4                     6.5
  Lymphomas and myeloma                   19.2                                        6.4                                     Lymphomas and myeloma         55.0                     5.2                             Lymphomas and myeloma         16.2                     5.4
  Prostate                                19.2                                        6.4                                     Pancreas                      53.6                     5.0                             Cervix uteri                  15.6                     5.2
  Stomach                                 17.1                                        5.7                                     Liver                         38.5                     3.6                             Leukaemia                     15.1                     5.0
  Colon and rectum                        14.3                                        4.8                                     Bladder                       37.6                     3.5                             Stomach                       13.1                     4.3
  Trachea, bronchus, and lung             14.0                                        4.6                                     Leukaemia                     37.2                     3.5                             Ovary                         8.8                      2.9
  Leukaemia                               12.4                                        4.1                                     Oesophagus                    29.2                     2.7                             Prostate                      8.5                      2.8
  Ovary                                   6.9                                         2.3                                     Ovary                         25.7                     2.4                             Pancreas                      7.0                      2.3
  Bladder                                 6.3                                         2.1                                     Mouth and oropharynx          24.9                     2.3                             Bladder                       6.2                      2.1
  Melanoma of the skin                    5.3                                         1.8                                     Corpus uteri                  16.0                     1.5                             Oesophagus                    5.9                      2.0
  Pancreas                                5.3                                         1.8                                     Melanoma of the skin          15.5                     1.5                             Corpus uteri                  4.1                      1.4
  Corpus uteri                            1.7                                         0.6                                     Cervix uteri                  8.3                      0.8                             Melanoma of the skin          1.8                      0.6
                                                                                                                                                                                                                                                                            
  Males                                                                                                                                                                                                                                                                     
  Liver                                   24.9                                        15.9                                    Trachea, bronchus, and lung   158.0                    26.6                            Trachea, bronchus, and lung   40.8                     25.2
  Prostate                                19.2                                        12.2                                    Colon and rectum              72.0                     12.1                            Liver                         28.4                     17.6
  Mouth and oropharynx                    14.4                                        9.2                                     Prostate                      70.1                     11.8                            Colon and rectum              14.6                     9.1
  Lymphomas and myeloma                   14.0                                        8.9                                     Stomach                       38.8                     6.5                             Mouth and oropharynx          13.8                     8.5
  Oesophagus                              13.8                                        8.8                                     Lymphomas and myeloma         27.6                     4.6                             Lymphomas and myeloma         10.0                     6.2
  Stomach                                 9.9                                         6.3                                     Bladder                       27.1                     4.6                             Prostate                      8.5                      5.3
  Trachea, bronchus, and lung             9.4                                         6.0                                     Pancreas                      26.7                     4.5                             Leukaemia                     7.8                      4.8
  Colon and rectum                        9.0                                         5.7                                     Liver                         25.3                     4.3                             Stomach                       7.5                      4.6
  Leukaemia                               7.3                                         4.7                                     Oesophagus                    21.4                     3.6                             Bladder                       4.7                      2.9
  Bladder                                 4.3                                         2.7                                     Leukaemia                     20.0                     3.4                             Pancreas                      3.6                      2.2
  Pancreas                                2.8                                         1.8                                     Mouth and oropharynx          19.2                     3.2                             Oesophagus                    3.6                      2.2
  Melanoma of the skin                    2.3                                         1.4                                     Melanoma of the skin          8.3                      1.4                             Melanoma of the skin          0.7                      0.5
                                                                                                                                                                                                                                                                            
  Females                                                                                                                                                                                                                                                                   
  Cervix uteri                            37.3                                        25.9                                    Breast                        91.8                     19.6                            Breast                        29.3                     21.1
  Breast                                  23.8                                        16.5                                    Colon and rectum              69.6                     14.9                            Cervix uteri                  15.6                     11.3
  Liver                                   10.3                                        7.2                                     Trachea, bronchus, and lung   49.2                     10.5                            Colon and rectum              13.9                     10.0
  Stomach                                 7.2                                         5.0                                     Stomach                       27.8                     6.0                             Liver                         11.0                     7.9
  Mouth and oropharynx                    7.2                                         5.0                                     Lymphomas and myeloma         27.4                     5.9                             Ovary                         8.8                      6.3
  Ovary                                   6.9                                         4.8                                     Pancreas                      26.9                     5.8                             Trachea, bronchus, and lung   7.5                      5.4
  Oesophagus                              6.8                                         4.8                                     Ovary                         25.7                     5.5                             Leukaemia                     7.2                      5.2
  Colon and rectum                        5.3                                         3.7                                     Leukaemia                     17.2                     3.7                             Lymphomas and myeloma         6.2                      4.5
  Lymphomas and myeloma                   5.3                                         3.7                                     Corpus uteri                  16.0                     3.4                             Mouth and oropharynx          5.6                      4.0
  Leukaemia                               5.1                                         3.5                                     Liver                         13.3                     2.8                             Stomach                       5.6                      4.0
  Trachea, bronchus, and lung             4.5                                         3.2                                     Bladder                       10.5                     2.2                             Corpus uteri                  4.1                      2.9
  Melanoma of the skin                    3.0                                         2.1                                     Cervix uteri                  8.3                      1.8                             Pancreas                      3.4                      2.4
  Pancreas                                2.5                                         1.8                                     Oesophagus                    7.8                      1.7                             Oesophagus                    2.4                      1.7
  Bladder                                 2.0                                         1.4                                     Melanoma of the skin          7.2                      1.5                             Bladder                       1.5                      1.1
  Corpus uteri                            1.7                                         1.2                                     Mouth and oropharynx          5.7                      1.2                             Melanoma of the skin          1.0                      0.7

There is a significant variation in the distribution of site-specific cancer mortality by region. In AfrE, the leading causes of cancer mortality in males and females were liver and cervix uteri cancers, respectively, both of which are primarily due to viral infections. Liver cancer accounted for approximately one quarter of all male cancer deaths and cervical cancer accounted for more than one-third of female cancer deaths. In EurA, the pattern of cancer mortality distribution is a typical one observed in industrialised countries: lung, colorectal, and prostate cancers accounted for a large proportion of male cancer mortality while breast, colorectal, and lung cancers were major causes among females. Site-specific cancer mortality distribution in SearB lay somewhere between the two sub regions, although lung and breast cancers were already leading causes of cancer deaths in males and females, respectively.

Cancer incidence by site
------------------------

Regional incidence was back calculated from multiplying mortality by site-specific incidence-to-mortality rate ratios by age, sex, and region. As shown in Table [10](#T10){ref-type="table"}, (age-standardised) incidence-to-mortality rate ratio was generally higher in cancers with relatively better prognosis including lymphoma, leukaemia, and cancers of colon and rectum, breast, uterus, and ovary. As a result, the new cases of such cancers as a proportion of total new cases were higher than the proportion of mortality from same cancers. Although this pattern was consistent across the regions, the ratios varied substantially by age, sex, and region (data not shown).

###### 

Estimated global site-specific cancer incidence-to-mortality rate ratios by sex

  Site                             Male   Female
  -------------------------------- ------ --------
  Mouth and oropharynx             1.20   1.57
  Oesophagus                       1.05   1.05
  Stomach                          1.15   1.19
  Colon and rectum                 1.69   1.75
  Liver                            1.01   1.06
  Pancreas                         1.02   1.01
  Trachea, bronchus, and lung      1.07   1.10
  Melanoma of the skin             3.37   2.93
  Breast                                  2.19
  Cervix uteri                            1.91
  Corpus uteri                            4.45
  Ovary                                   1.70
  Prostate                         2.08   
  Bladder                          2.21   2.01
  Lymphomas and multiple myeloma   1.40   1.51
  Leukaemia                        1.35   1.44
  Other malignant neoplasms        1.49   1.63

Tables [11](#T11){ref-type="table"},[12](#T12){ref-type="table"},[13](#T13){ref-type="table"} show the regional estimates of total new cases and age-specific incidence rates of all cancers in 2000. More than 10 million new cancers cases occurred world wide. Due to the differences in survival by region, estimated incidence-to-mortality rate ratios were generally much higher in developed regions and the proportion of cancer incidence in developing regions was approximately 50% of total cancer incidence in the world. Despite their much smaller population size, the number of new cases in AmrA and EurA are comparable to those in SearD and WprB1. On average global cancer incidence rates among males and females were 169.7 and 171.1 per 100,000, respectively (Figure [4](#F4){ref-type="fig"}). Regional age-standardised incidence rates also suggest that female incidence was slightly higher than male incidence in developing regions, particularly in AmrD where the number of deaths female cancers was high. On the other hand, male and female incidence rates were almost the same in all A sub regions (AmrA, EurA, and WprA).

![Age-standardised incidence rate from all cancers by region, 2000](1471-2407-2-37-4){#F4}

###### 

Estimated global and regional number of new cases (thousands) and incidence rate (per 100,000) of all cancers by age, both sexes, 2000

                                            Age group                                                              
  ----------------------------------------- ----------- ------ ------- ------- -------- -------- -------- -------- ---------
  Number of new cases (000s)                                                                                       
  World                                     136.8       96.5   360.1   923.3   2459.3   2641.4   2514.5   1160.2   10292.1
  AfrD                                      12.5        4.6    24.7    41.9    87.6     90.8     74.5     31.9     368.6
  AfrE                                      12.8        4.9    33.8    49.1    99.2     102.4    81.0     31.9     415.1
  AmrA                                      3.0         3.3    22.7    110.4   306.3    308.4    404.2    176.4    1334.8
  AmrB                                      10.0        8.5    31.5    76.1    150.8    137.5    127.6    69.2     611.1
  AmrD                                      2.9         2.6    7.5     15.6    28.5     23.8     22.7     11.9     115.5
  EmrB                                      3.5         4.3    8.8     15.7    28.4     24.0     20.5     7.9      113.2
  EmrD                                      5.4         4.7    9.3     20.0    28.2     19.9     15.1     4.4      106.9
  EurA                                      2.7         3.6    23.8    96.6    323.0    421.1    531.4    322.2    1724.3
  EurB1                                     2.1         2.2    11.0    33.8    91.6     105.0    84.4     27.1     357.2
  EurB2                                     0.6         1.2    3.7     8.4     11.7     14.0     8.7      1.9      50.2
  EurC                                      2.6         3.5    18.0    60.8    172.9    222.9    180.5    46.1     707.3
  SearB                                     8.8         7.5    18.9    65.1    138.9    103.9    67.6     26.7     437.5
  SearD                                     39.6        24.2   85.1    111.0   277.0    317.7    208.4    110.8    1173.9
  WprA                                      0.9         0.9    6.8     25.7    108.2    133.0    153.0    107.7    536.1
  WprB1                                     26.9        18.3   47.7    176.3   575.8    593.2    516.0    170.3    2124.4
  WprB2                                     2.5         2.0    6.6     15.6    29.5     22.9     18.2     13.6     110.8
  WprB3                                     0.1         0.1    0.4     1.2     1.9      0.9      0.5      0.2      5.2
                                                                                                                   
  Age-specific incidence rate per 100,000                                                                          
  World                                     22.6        8.1    23.0    72.4    305.6    781.8    1276.6   1830.7   170.4
  AfrD                                      22.9        5.2    26.8    78.9    310.4    866.4    1554.9   2834.8   110.4
  AfrE                                      22.3        5.2    36.3    94.3    371.8    1070.3   1812.2   2975.0   123.0
  AmrA                                      14.4        7.5    36.4    150.7   532.9    1356.3   2232.0   1994.7   433.0
  AmrB                                      21.9        9.5    25.4    82.0    279.1    676.3    1103.7   1842.4   138.2
  AmrD                                      30.8        15.1   36.5    123.3   406.3    881.5    1623.0   2921.2   162.0
  EmrB                                      21.4        12.3   21.4    62.2    213.6    494.3    793.5    1206.4   81.1
  EmrD                                      28.9        14.2   23.8    78.2    205.5    401.7    619.9    728.7    77.5
  EurA                                      12.4        7.5    29.6    102.1   412.5    1008.3   1681.0   2406.4   421.6
  EurB1                                     17.0        8.5    25.3    95.7    349.8    826.0    1056.8   1355.2   215.4
  EurB2                                     10.5        9.7    26.6    81.0    254.7    577.3    674.1    560.0    98.7
  EurC                                      20.6        10.3   32.4    109.7   403.0    901.9    1125.9   1048.5   288.5
  SearB                                     21.4        9.3    16.8    77.4    297.8    575.8    776.5    1142.3   110.9
  SearD                                     24.4        7.9    22.9    42.4    182.7    544.1    738.9    1521.0   87.1
  WprA                                      10.9        5.8    22.1    86.1    334.2    808.6    1361.9   2273.3   360.0
  WprB1                                     26.1        7.8    14.0    52.3    278.2    728.1    1193.0   1475.8   156.5
  WprB2                                     16.6        6.3    15.8    51.7    210.3    378.2    572.8    1565.2   78.0
  WprB3                                     11.7        7.7    21.6    93.3    271.0    364.6    422.9    1174.1   76.4

###### 

Estimated global and regional number of new cases (thousands) and incidence rate (per 100,000) of all cancers by age, males, 2000

                                            Age group                                                              
  ----------------------------------------- ----------- ------ ------- ------- -------- -------- -------- -------- --------
  Number of new cases (000s)                                                                                       
  World                                     64.5        50.9   154.0   257.7   1174.2   1528.4   1380.8   556.5    5167.1
  AfrD                                      5.2         2.3    10.4    13.0    37.9     45.1     39.0     17.3     170.2
  AfrE                                      6.6         2.8    15.3    18.3    42.5     47.2     40.0     17.2     189.9
  AmrA                                      1.6         1.7    11.0    28.3    134.7    174.3    226.6    109.9    688.2
  AmrB                                      5.3         4.4    13.9    15.7    56.1     70.5     68.2     34.6     268.7
  AmrD                                      1.2         1.4    2.8     2.6     7.2      10.5     11.2     6.0      42.9
  EmrB                                      2.2         2.5    3.6     3.4     13.2     14.7     13.1     4.9      57.5
  EmrD                                      3.4         2.7    4.3     6.3     13.3     11.5     8.5      2.7      52.8
  EurA                                      1.5         2.0    11.5    26.4    153.8    250.2    291.4    139.6    876.3
  EurB1                                     1.1         1.3    4.8     10.8    49.4     63.2     45.7     12.2     188.5
  EurB2                                     0.4         0.7    1.6     2.2     5.3      7.9      4.3      0.7      23.1
  EurC                                      1.4         1.8    8.1     17.5    90.3     126.3    84.3     16.0     345.6
  SearB                                     4.3         3.3    7.0     11.8    57.2     59.7     39.5     13.0     195.8
  SearD                                     16.2        11.8   27.0    29.8    110.2    173.8    113.7    49.1     531.6
  WprA                                      0.5         0.5    3.0     5.8     51.0     86.0     94.3     51.3     292.3
  WprB1                                     12.3        10.5   27.1    61.4    337.9    373.6    289.8    74.8     1187.5
  WprB2                                     1.2         1.0    2.5     4.2     13.5     13.5     11.0     7.2      54.2
  WprB3                                     0.1         0.1    0.1     0.2     0.7      0.5      0.3      0.1      2.0
                                                                                                                   
  Age-specific incidence rate per 100,000                                                                          
  World                                     20.8        8.3    19.2    39.8    291.3    946.2    1624.8   2320.5   169.7
  AfrD                                      18.7        5.2    22.6    49.5    277.5    921.0    1801.5   3472.3   102.4
  AfrE                                      23.1        5.9    32.8    70.5    328.9    1075.5   2067.8   4109.5   113.2
  AmrA                                      15.3        7.6    34.8    76.6    474.1    1614.6   2897.4   3261.5   451.0
  AmrB                                      22.6        9.6    22.4    34.4    215.1    745.8    1347.6   2190.5   122.6
  AmrD                                      25.6        16.0   27.0    42.0    212.4    814.8    1742.9   3320.7   120.7
  EmrB                                      26.0        13.8   17.2    25.2    181.4    584.4    1018.0   1464.3   79.6
  EmrD                                      36.1        16.2   21.6    48.4    199.2    503.8    791.2    1024.4   75.6
  EurA                                      13.3        8.2    27.9    55.2    394.2    1262.9   2233.2   2960.3   435.9
  EurB1                                     18.5        9.5    21.8    60.5    383.2    1081.9   1403.2   1668.1   229.1
  EurB2                                     13.5        10.6   22.9    43.2    238.3    710.9    851.6    678.2    91.7
  EurC                                      21.4        10.7   28.7    63.8    451.9    1248.4   1667.0   1551.3   299.9
  SearB                                     20.3        8.0    12.3    28.1    250.5    702.6    1001.8   1284.1   99.2
  SearD                                     19.4        7.5    14.0    21.8    141.7    606.1    847.2    1430.6   76.5
  WprA                                      12.8        6.7    18.9    38.6    316.3    1088.7   1953.2   2971.8   398.4
  WprB1                                     22.7        8.6    15.4    35.5    316.0    908.2    1480.4   1753.4   170.2
  WprB2                                     15.4        6.6    11.6    28.6    207.3    500.1    835.9    2327.7   77.2
  WprB3                                     13.5        9.0    10.5    27.9    214.4    400.7    515.2    1412.7   57.5

###### 

Estimated global and regional number of new cases (thousands) and incidence rate (per 100,000) of all cancers by age, females, 2000

                                            Age group                                                              
  ----------------------------------------- ----------- ------ ------- ------- -------- -------- -------- -------- --------
  Number of new cases (000s)                                                                                       
  World                                     72.3        45.6   206.1   665.6   1285.1   1112.9   1133.6   603.7    5125.0
  AfrD                                      7.4         2.3    14.2    28.9    49.6     45.8     35.6     14.7     198.4
  AfrE                                      6.1         2.1    18.5    30.8    56.7     55.1     41.0     14.8     225.2
  AmrA                                      1.4         1.6    11.7    82.1    171.6    134.2    177.7    66.5     646.7
  AmrB                                      4.7         4.1    17.5    60.4    94.7     66.9     59.5     34.6     342.4
  AmrD                                      1.7         1.2    4.7     13.0    21.3     13.3     11.5     5.9      72.6
  EmrB                                      1.3         1.8    5.2     12.4    15.2     9.3      7.4      3.0      55.6
  EmrD                                      1.9         2.0    5.0     13.7    14.9     8.4      6.6      1.7      54.1
  EurA                                      1.2         1.6    12.3    70.2    169.2    170.9    240.0    182.7    848.0
  EurB1                                     0.9         0.9    6.2     23.0    42.2     41.8     38.7     14.9     168.8
  EurB2                                     0.2         0.5    2.1     6.2     6.4      6.1      4.4      1.2      27.1
  EurC                                      1.2         1.6    9.9     43.3    82.7     96.7     96.2     30.2     361.7
  SearB                                     4.5         4.2    11.9    53.3    81.7     44.2     28.1     13.7     241.7
  SearD                                     23.4        12.4   58.1    81.2    166.8    143.8    94.7     61.7     642.2
  WprA                                      0.3         0.4    3.8     19.9    57.2     47.1     58.7     56.4     243.8
  WprB1                                     14.6        7.8    20.6    114.8   237.8    219.6    226.2    95.5     936.9
  WprB2                                     1.3         0.9    4.1     11.4    15.9     9.3      7.2      6.3      56.5
  WprB3                                     0.0         0.1    0.3     1.0     1.1      0.4      0.2      0.1      3.2
                                                                                                                   
  Age-specific incidence rate per 100,000                                                                          
  World                                     24.6        7.9    27.0    106.1   320.0    631.1    1012.3   1532.5   171.1
  AfrD                                      27.2        5.1    30.9    107.8   341.2    818.6    1352.1   2330.7   118.3
  AfrE                                      21.6        4.6    39.8    117.9   412.0    1065.8   1616.9   2253.0   132.6
  AmrA                                      13.5        7.4    38.1    226.2   590.3    1123.0   1726.5   1214.7   415.3
  AmrB                                      21.2        9.3    28.4    127.8   339.0    615.8    914.1    1589.7   153.5
  AmrD                                      36.2        14.2   46.1    200.8   588.6    942.4    1521.8   2602.4   203.0
  EmrB                                      16.6        10.7   25.8    104.3   252.3    397.3    571.2    937.3    82.8
  EmrD                                      21.5        12.1   26.1    109.2   211.4    315.0    484.3    495.4    79.3
  EurA                                      11.5        6.8    31.5    150.3   430.7    778.6    1292.8   2105.4   407.8
  EurB1                                     15.4        7.4    29.0    131.6   317.4    608.6    818.5    1175.8   202.0
  EurB2                                     7.5         8.8    30.4    117.2   270.0    464.6    559.4    504.5    105.5
  EurC                                      19.7        9.9    36.1    154.6   360.5    661.9    876.5    895.0    278.3
  SearB                                     22.5        10.8   21.3    126.4   343.1    463.0    589.7    1033.9   122.7
  SearD                                     29.8        8.3    32.6    64.8    225.9    484.2    640.6    1601.5   98.4
  WprA                                      9.0         4.9    25.5    134.4   351.9    550.0    916.0    1873.2   322.7
  WprB1                                     29.8        7.0    12.5    70.1    237.8    544.5    955.4    1312.9   142.1
  WprB2                                     17.9        6.1    20.2    73.7    212.9    279.2    386.9    1138.6   78.8
  WprB3                                     9.6         6.3    33.4    166.5   328.3    330.2    343.6    973.9    96.5

Estimated global and regional numbers of new cases and age-standardised incidence rates for 17 cancer sites by sex are shown in Tables [14](#T14){ref-type="table"} and [15](#T15){ref-type="table"}. As in mortality distribution, there is a significant variations in the distribution of site-specific cancer incidence by region (Tables [16](#T16){ref-type="table"} and [17](#T17){ref-type="table"}). The distribution of cancer incidence was almost similar to that of mortality: lung cancer was the most common cancer in the world in 2000, accounting for 13% of total cancer mortality, followed by cancers of stomach (10% of total), liver (10%), colon and rectum (10%), and breast (6%). The variations in the distribution of site-specific new cases of cancer by region were also similar to those observed in mortality distribution. In all regions, compared to proportion of total mortality, the proportion of lung cancer decreased while that of colon and rectum, breast, uterus and prostate increased, suggesting the difference in survival by cancer site as suggested above.

###### 

Estimated global and regional number of new cases and age-standardised incidence rate of cancer by site, males, 2000

                                                            WHO sub region                                                                                                                
  ------------------------------------------------- ------- ---------------- ------ ------- ------ ------ ------ ------ ------- ------ ------ ------ ------ ------- ------ ------- ------ ------
  **Number of new cases (000s)**                                                                                                                                                          
  Mouth and oropharynx cancers                      267.1   12.1             16.5   11.3    10.4   0.9    2.6    1.7    28.7    7.4    0.9    17.8   16.0   98.1    6.5    29.7    6.1    0.5
  Oesophagus cancer                                 286.5   5.1              14.1   12.4    11.1   0.7    1.9    0.8    22.8    3.6    1.8    10.7   3.8    42.0    10.1   142.7   3.0    0.0
  Stomach cancer                                    589.3   13.3             10.9   11.8    29.7   8.7    8.6    2.5    45.6    17.2   4.0    48.6   8.6    30.1    40.6   300.9   7.6    0.1
  Colon and rectum cancers                          527.8   9.5              12.0   85.6    21.2   2.2    3.2    3.1    133.8   21.5   1.4    42.8   21.4   25.7    49.2   91.0    3.8    0.1
  Liver cancer                                      422.0   20.0             23.6   9.0     9.5    2.9    3.1    2.3    26.1    6.0    0.7    7.9    28.6   18.4    24.6   232.8   6.2    0.2
  Pancreas cancer                                   119.3   1.5              2.8    16.5    8.1    1.2    0.9    1.0    27.4    5.9    1.0    11.4   3.7    7.3     11.5   18.7    0.5    0.0
  Trachea, bronchus, lung cancers                   939.9   7.4              9.8    112.1   38.5   1.7    9.3    7.4    172.0   49.5   3.9    89.3   43.1   107.8   46.9   227.8   13.1   0.3
  Melanoma of the skin                              118.2   3.5              3.4    61.8    5.3    0.9    0.3    0.2    22.6    3.2    0.3    4.0    1.2    2.1     6.7    2.6     0.1    0.1
  Breast cancer                                     0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Cervix uteri cancer                               0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Corpus uteri cancer                               0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Ovary cancer                                      0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Prostate cancer                                   550.2   36.5             28.2   165.7   46.0   8.6    3.2    2.7    139.1   15.2   0.8    22.3   13.4   29.6    28.1   9.5     1.2    0.0
  Bladder cancer                                    277.2   10.6             7.3    60.3    8.1    0.8    4.1    14.4   65.1    12.1   1.2    17.8   7.7    27.8    13.5   24.8    1.5    0.0
  Lymphomas, multiple myeloma                       238.5   20.3             18.6   36.2    13.4   2.8    6.5    5.2    39.3    7.8    1.3    7.4    13.3   36.5    11.8   15.2    2.6    0.2
  Leukaemia                                         195.2   6.3              9.2    20.6    13.1   2.9    3.4    5.3    25.6    6.6    1.1    9.3    10.7   28.2    6.7    44.0    2.2    0.1
  Other malignant neoplasms                         635.8   24.2             33.5   84.8    54.2   8.6    10.3   6.2    128.4   32.5   4.7    56.3   24.2   77.8    35.8   47.7    6.4    0.3
                                                                                                                                                                                          
  **Age-standardised incidence rate per 100,000**                                                                                                                                         
  Mouth and oropharynx cancers                      8.8     12.9             18.4   5.0     5.5    3.3    4.9    3.6    8.6     7.4    4.5    10.9   9.3    18.5    4.7    3.9     12.0   21.7
  Oesophagus cancer                                 9.4     5.7              16.8   5.1     5.9    3.1    3.8    1.7    6.0     3.4    9.4    6.3    2.2    8.2     6.6    19.2    6.3    2.0
  Stomach cancer                                    19.4    15.0             13.0   4.6     15.8   35.8   17.4   5.5    11.0    16.4   21.3   28.8   5.2    5.9     25.6   40.8    15.9   3.8
  Colon and rectum cancers                          17.3    10.4             14.6   34.4    11.3   9.2    6.3    6.5    33.0    20.4   7.1    25.1   12.9   4.9     32.4   12.3    7.8    5.8
  Liver cancer                                      13.7    20.3             24.7   3.7     5.0    11.4   6.4    5.0    6.4     5.7    3.6    4.8    16.0   3.2     16.2   30.8    12.1   9.9
  Pancreas cancer                                   3.9     1.6              3.5    6.5     4.3    4.8    1.8    2.3    6.8     5.7    5.3    6.8    2.2    1.5     7.3    2.5     1.0    0.2
  Trachea, bronchus, lung cancers                   30.9    8.3              12.0   44.8    20.6   6.9    18.9   16.6   43.3    47.1   20.6   52.2   27.5   20.3    28.9   30.8    26.4   14.7
  Melanoma of the skin                              3.9     3.8              3.7    27.2    2.8    3.7    0.6    0.3    6.6     3.1    1.6    2.6    0.7    0.4     4.9    0.3     0.3    3.6
  Breast cancer                                     0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Cervix uteri cancer                               0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Corpus uteri cancer                               0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Ovary cancer                                      0.0     0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Prostate cancer                                   18.0    45.0             38.9   63.7    24.8   36.3   6.9    6.5    31.8    14.1   4.4    12.8   8.6    5.8     17.1   1.3     2.5    2.3
  Bladder cancer                                    9.0     12.0             8.8    24.4    4.3    3.3    8.5    30.5   16.1    11.6   6.4    10.7   4.6    4.8     8.7    3.5     3.1    1.4
  Lymphomas, multiple myeloma                       7.8     18.2             17.0   15.3    6.8    10.7   10.6   8.6    10.9    8.1    6.2    5.1    7.6    6.1     8.2    2.1     4.5    7.1
  Leukaemia                                         6.4     5.5              7.7    8.9     6.3    8.6    5.1    7.8    7.5     7.2    4.3    6.8    5.7    4.3     5.8    6.7     3.3    3.3
  Other malignant neoplasms                         20.8    24.1             37.1   39.9    27.2   31.0   19.1   11.3   39.1    32.8   22.4   37.5   13.5   13.7    27.0   6.6     12.4   11.2

###### 

Estimated global and regional number of new cases and age-standardised incidence rate of cancer by site, females, 2000

                                                             WHO sub region                                                                                                                
  ------------------------------------------------- -------- ---------------- ------ ------- ------ ------ ------ ------ ------- ------ ------ ------ ------ ------- ------ ------- ------ ------
  **Number of new cases (000s)**                                                                                                                                                           
  Mouth and oropharynx cancers                      153.6    8.2              11.4   5.9     4.6    0.8    2.2    1.1    9.9     2.5    0.5    4.6    9.4    63.6    3.0    21.2    4.2    0.4
  Oesophagus cancer                                 166.2    4.2              7.2    3.3     4.0    0.3    1.6    0.5    8.4     1.0    1.3    3.8    2.5    34.9    2.1    89.0    2.0    0.0
  Stomach cancer                                    383.9    10.3             8.4    7.1     19.7   8.4    4.5    2.0    33.9    10.2   2.6    36.3   6.7    18.1    23.7   186.7   5.1    0.1
  Colon and rectum cancers                          517.3    8.5              8.2    73.8    26.2   3.3    4.0    2.8    131.0   19.0   1.8    54.1   22.8   21.1    41.7   95.5    3.3    0.1
  Liver cancer                                      204.4    11.9             11.1   4.7     9.7    3.4    1.3    1.2    14.0    4.0    0.5    5.9    11.7   12.0    11.1   99.6    2.2    0.2
  Pancreas cancer                                   106.9    1.6              2.6    14.3    9.1    1.3    0.8    0.7    28.1    4.8    0.7    10.2   3.6    5.3     9.8    13.6    0.5    0.0
  Trachea, bronchus, lung cancers                   365.7    3.1              5.0    74.6    16.4   1.0    3.0    2.6    55.3    10.8   1.1    17.7   8.3    25.9    18.9   117.7   4.0    0.2
  Melanoma of the skin                              88.5     3.3              4.3    26.5    5.7    0.9    0.4    0.3    26.5    3.5    0.3    5.9    1.9    1.7     5.0    2.2     0.1    0.1
  Breast cancer                                     1031.9   28.3             39.8   226.5   59.3   7.2    10.2   13.6   221.8   32.6   4.5    68.5   53.9   109.0   43.7   102.1   10.2   0.5
  Cervix uteri cancer                               487.5    43.3             67.9   16.1    40.6   9.2    6.7    5.6    18.8    12.6   1.9    22.5   32.8   146.7   6.6    45.0    10.2   0.8
  Corpus uteri cancer                               326.3    4.6              6.0    46.0    48.8   8.6    1.6    1.3    68.3    17.9   3.8    43.6   19.9   11.7    17.3   17.4    0.8    0.1
  Ovary cancer                                      221.3    7.1              12.2   22.4    13.2   2.1    2.1    2.0    39.4    10.0   1.2    21.6   18.1   31.9    8.4    26.6    2.9    0.2
  Prostate cancer                                   0.0      0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Bladder cancer                                    105.7    3.6              3.4    14.9    3.5    0.4    0.8    3.7    21.4    2.7    0.3    4.4    2.4    28.9    4.6    9.7     1.0    0.0
  Lymphomas, multiple myeloma                       242.6    10.2             8.0    32.2    12.4   2.3    5.0    4.0    40.9    6.9    1.0    7.3    9.6    74.9    9.7    15.2    2.7    0.1
  Leukaemia                                         169.5    5.9              7.0    14.7    12.4   2.9    2.6    3.8    23.0    4.9    0.9    9.0    10.8   24.9    5.2    39.4    1.9    0.1
  Other malignant neoplasms                         553.9    44.2             22.7   63.6    56.7   11.7   8.9    8.9    107.3   25.3   4.4    46.5   27.3   31.7    32.7   56.1    5.3    0.3
                                                                                                                                                                                           
  **Age-standardised incidence rate per 100,000**                                                                                                                                          
  Mouth and oropharynx cancers                      5.1      9.2              12.6   2.6     2.4    3.4    4.6    2.2    2.7     2.5    2.5    2.2    5.7    13.5    2.2    3.1     7.7    18.6
  Oesophagus cancer                                 5.6      5.2              9.2    1.3     2.2    1.5    4.0    1.1    1.8     1.0    6.5    1.5    1.7    8.0     1.3    13.4    3.9    1.8
  Stomach cancer                                    12.8     12.7             10.5   2.9     10.7   37.4   10.9   4.3    7.3     9.4    12.4   15.6   4.4    4.3     14.9   28.2    10.1   3.1
  Colon and rectum cancers                          17.3     9.9              10.2   29.8    14.1   14.4   9.4    5.9    29.2    17.2   8.6    23.0   14.7   4.7     26.7   14.2    6.3    4.2
  Liver cancer                                      6.8      13.0             12.0   1.9     5.2    14.6   3.1    2.5    3.1     3.6    2.3    2.5    7.5    2.3     6.6    14.8    4.2    7.6
  Pancreas cancer                                   3.6      1.8              3.5    5.6     5.0    5.8    1.9    1.6    6.0     4.3    3.6    4.3    2.4    1.3     5.8    2.1     0.9    0.4
  Trachea, bronchus, lung cancers                   11.9     3.5              5.8    30.5    8.8    4.4    6.7    5.6    13.4    9.9    5.5    7.6    5.4    5.3     11.6   16.0    7.4    8.4
  Melanoma of the skin                              2.9      3.9              5.3    12.6    2.9    4.0    0.8    0.6    7.9     3.4    1.4    3.2    1.2    0.3     4.2    0.3     0.2    2.8
  Breast cancer                                     34.2     29.9             41.6   103.5   29.7   27.6   22.5   26.2   64.1    32.0   21.2   35.4   30.7   20.9    38.6   14.1    18.5   21.9
  Cervix uteri cancer                               16.6     43.3             69.8   8.2     19.8   34.9   15.0   10.7   6.2     12.8   9.0    12.7   18.4   30.2    6.0    6.6     18.0   33.1
  Corpus uteri cancer                               10.8     5.2              6.8    20.3    24.5   32.8   3.7    2.8    18.4    17.1   18.1   21.2   11.5   2.1     13.3   2.4     1.5    5.2
  Ovary cancer                                      7.3      6.8              12.1   9.8     6.6    7.9    4.3    3.7    10.8    9.9    5.6    11.2   10.2   6.2     6.8    3.6     5.0    6.3
  Prostate cancer                                   0.0      0.0              0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0    0.0    0.0    0.0     0.0    0.0     0.0    0.0
  Bladder cancer                                    3.6      4.1              3.9    6.0     1.9    1.8    2.2    7.9    4.6     2.4    1.5    1.9    1.6    5.7     2.7    1.5     1.8    0.6
  Lymphomas, multiple myeloma                       8.3      9.1              7.7    13.8    6.3    9.2    9.9    7.2    10.6    7.0    4.4    4.0    5.8    15.7    6.7    2.2     4.4    4.8
  Leukaemia                                         5.5      5.6              6.1    6.6     6.0    9.1    4.3    5.9    6.0     5.2    3.8    5.2    6.0    3.9     4.4    5.8     3.0    2.9
  Other malignant neoplasms                         18.8     45.9             24.0   30.2    28.6   44.0   20.0   17.2   29.6    24.9   19.6   25.8   16.1   6.1     23.3   10.7    9.4    129

###### 

Ranking of the global cancer incidence by site, 2000

  site                          Number of death (000s)   Proportion of total (%)
  ----------------------------- ------------------------ -------------------------
  **Both sexes**                                         
  Trachea, bronchus, and lung   1305.6                   12.7
  Stomach                       1045.0                   10.2
  Liver                         1031.9                   10.0
  Colon and rectum              973.1                    9.5
  Breast                        626.4                    6.1
  Oesophagus                    550.2                    5.3
  Lymphomas and myeloma         487.5                    4.7
  Mouth and oropharynx          481.1                    4.7
  Prostate                      452.7                    4.4
  Leukaemia                     420.7                    4.1
  Cervix uteri                  382.9                    3.7
  Pancreas                      364.7                    3.5
  Bladder                       326.3                    3.2
  Ovary                         226.2                    2.2
  Corpus uteri                  221.3                    2.2
  Melanoma of the skin          206.7                    2.0
                                                         
  **Males**                                              
  Trachea, bronchus, and lung   939.9                    18.2
  Stomach                       589.3                    11.4
  Liver                         550.2                    10.6
  Colon and rectum              527.8                    10.2
  Oesophagus                    422.0                    8.2
  Prostate                      286.5                    5.5
  Mouth and oropharynx          277.2                    5.4
  Lymphomas and myeloma         267.1                    5.2
  Leukaemia                     238.5                    4.6
  Bladder                       195.2                    3.8
  Pancreas                      119.3                    2.3
  Melanoma of the skin          118.2                    2.3
                                                         
  **Females**                                            
  Breast                        1031.9                   20.1
  Trachea, bronchus, and lung   517.3                    10.1
  Stomach                       487.5                    9.5
  Colon and rectum              383.9                    7.5
  Cervix uteri                  365.7                    7.1
  Liver                         326.3                    6.4
  Lymphomas and myeloma         242.6                    4.7
  Oesophagus                    221.3                    4.3
  Ovary                         204.4                    4.0
  Leukaemia                     169.5                    3.3
  Pancreas                      166.2                    3.2
  Mouth and oropharynx          153.6                    3.0
  Corpus uteri                  106.9                    2.1
  Bladder                       105.7                    2.1
  Melanoma of the skin          88.5                     1.7

###### 

Ranking of the selected regional cancer incidence by site, 2000

  WHO sub region                                                                                                                                                                                                                   
  --------------------------------------- ------------------------------------------- --------------------------------------- ----------------------------- -------- ---------------------- ----------------------------- -------- ------
  AfrE (high child and adult mortality)   EurA (very low child and adult mortality)   SearB (low child and adult mortality)                                                                                                        
                                                                                                                                                                                                                                   
  site                                    Number of Proportion                        site                                    Number of Proportion          site     Number of Proportion                                          
                                          (000s)                                      (%)                                                                   (000s)   (%)                                                  (000s)   (%)
                                                                                                                                                                                                                                   
  **Both sexes**                                                                                                                                                                                                                   
  Cervix uteri                            67.9                                        16.4                                    Trachea, bronchus, and lung   264.7    15.4                   Trachea, bronchus, and lung   53.9     12.3
  Liver                                   39.8                                        9.6                                     Colon and rectum              227.3    13.2                   Liver                         51.4     11.7
  Breast                                  34.7                                        8.3                                     Breast                        221.8    12.9                   Breast                        44.3     10.1
  Mouth and oropharynx                    28.2                                        6.8                                     Prostate                      139.1    8.1                    Colon and rectum              40.3     9.2
  Oesophagus                              27.9                                        6.7                                     Stomach                       86.5     5.0                    Mouth and oropharynx          32.8     7.5
  Lymphomas and myeloma                   26.6                                        6.4                                     Lymphomas and myeloma         80.2     4.7                    Lymphomas and myeloma         25.4     5.8
  Prostate                                21.2                                        5.1                                     Pancreas                      79.6     4.6                    Cervix uteri                  22.9     5.2
  Stomach                                 20.3                                        4.9                                     Liver                         68.3     4.0                    Leukaemia                     21.5     4.9
  Colon and rectum                        19.4                                        4.7                                     Bladder                       55.5     3.2                    Stomach                       19.9     4.5
  Trachea, bronchus, and lung             16.2                                        3.9                                     Leukaemia                     49.1     2.8                    Ovary                         18.1     4.1
  Leukaemia                               14.8                                        3.6                                     Oesophagus                    48.6     2.8                    Prostate                      15.3     3.5
  Ovary                                   12.2                                        2.9                                     Ovary                         40.1     2.3                    Pancreas                      13.4     3.1
  Bladder                                 10.7                                        2.6                                     Mouth and oropharynx          39.4     2.3                    Bladder                       10.1     2.3
  Melanoma of the skin                    7.7                                         1.8                                     Corpus uteri                  38.6     2.2                    Oesophagus                    7.2      1.7
  Pancreas                                6.0                                         1.4                                     Melanoma of the skin          31.2     1.8                    Corpus uteri                  6.2      1.4
  Corpus uteri                            5.4                                         1.3                                     Cervix uteri                  18.8     1.1                    Melanoma of the skin          3.1      0.7
                                                                                                                                                                                                                                   
  **Males**                                                                                                                                                                                                                        
  Liver                                   28.2                                        14.8                                    Trachea, bronchus, and lung   172.0    19.6                   Trachea, bronchus, and lung   43.1     22.0
  Prostate                                23.6                                        12.4                                    Colon and rectum              139.1    15.9                   Liver                         28.6     14.6
  Mouth and oropharynx                    18.6                                        9.8                                     Prostate                      133.8    15.3                   Colon and rectum              21.4     11.0
  Lymphomas and myeloma                   16.5                                        8.7                                     Stomach                       65.1     7.4                    Mouth and oropharynx          16.0     8.2
  Oesophagus                              14.1                                        7.4                                     Lymphomas and myeloma         45.6     5.2                    Lymphomas and myeloma         13.4     6.9
  Stomach                                 12.0                                        6.3                                     Bladder                       39.3     4.5                    Prostate                      13.3     6.8
  Trachea, bronchus, and lung             10.9                                        5.8                                     Pancreas                      28.7     3.3                    Leukaemia                     10.7     5.5
  Colon and rectum                        9.8                                         5.2                                     Liver                         27.4     3.1                    Stomach                       8.6      4.4
  Leukaemia                               9.2                                         4.9                                     Oesophagus                    26.1     3.0                    Bladder                       7.7      3.9
  Bladder                                 7.3                                         3.8                                     Leukaemia                     25.6     2.9                    Pancreas                      3.8      1.9
  Pancreas                                3.4                                         1.8                                     Mouth and oropharynx          22.8     2.6                    Oesophagus                    3.7      1.9
  Melanoma of the skin                    2.8                                         1.5                                     Melanoma of the skin          22.6     2.6                    Melanoma of the skin          1.2      0.6
                                                                                                                                                                                                                                   
  **Females**                                                                                                                                                                                                                      
  Cervix uteri                            67.9                                        30.2                                    Breast                        221.8    26.2                   Breast                        53.9     22.3
  Breast                                  39.8                                        17.7                                    Colon and rectum              131.0    15.4                   Cervix uteri                  32.8     13.6
  Liver                                   12.2                                        5.4                                     Trachea, bronchus, and lung   68.3     8.1                    Colon and rectum              22.8     9.4
  Stomach                                 11.4                                        5.1                                     Stomach                       55.3     6.5                    Liver                         19.9     8.2
  Mouth and oropharynx                    11.1                                        4.9                                     Lymphomas and myeloma         40.9     4.8                    Ovary                         18.1     7.5
  Ovary                                   8.4                                         3.7                                     Pancreas                      39.4     4.6                    Trachea, bronchus, and lung   11.7     4.8
  Oesophagus                              8.2                                         3.7                                     Ovary                         33.9     4.0                    Leukaemia                     10.8     4.5
  Colon and rectum                        8.0                                         3.6                                     Leukaemia                     28.1     3.3                    Lymphomas and myeloma         9.6      4.0
  Lymphomas and myeloma                   7.2                                         3.2                                     Corpus uteri                  26.5     3.1                    Mouth and oropharynx          9.4      3.9
  Leukaemia                               7.0                                         3.1                                     Liver                         23.0     2.7                    Stomach                       8.3      3.4
  Trachea, bronchus, and lung             6.0                                         2.7                                     Bladder                       21.4     2.5                    Corpus uteri                  6.7      2.8
  Melanoma of the skin                    5.0                                         2.2                                     Cervix uteri                  18.8     2.2                    Pancreas                      3.6      1.5
  Pancreas                                4.3                                         1.9                                     Oesophagus                    14.0     1.7                    Oesophagus                    2.5      1.0
  Bladder                                 3.4                                         1.5                                     Melanoma of the skin          9.9      1.2                    Bladder                       2.4      1.0
  Corpus uteri                            2.6                                         1.2                                     Mouth and oropharynx          8.4      1.0                    Melanoma of the skin          1.9      0.8

Discussion
==========

Various attempts have been made to quantify the global burden of cancer and to estimate site-specific cancer mortality and morbidity \[[@B1],[@B12]-[@B15]\]. More recently, the efforts made by the International Agency for Research on Cancer (IARC) have led to the Globocan 2000 estimates, which has also used information on incidence and survival to estimate cancer death for the year 2000 from various sources including cancer registries \[[@B12],[@B13]\]. The analyses reported here have built extensively on the IARC work to synthesis and estimate cancer mortality and incidence distributions by site for all regions of the world. Compared to the estimates of the Globocan 2000, the GBD 2000 estimates for global cancer mortality and incidence are 11% and 3% higher, respectively. Although the overall difference in terms of proportion is small, the absolute difference between the two estimates remains relatively large. This difference is predominantly due to a substantially large difference in the AFRO, EMRO, and SEARO regions.

Some researchers suggest that model-based estimates of cancer mortality in GBD 1990 bear little relation to the actual profile of cancer recorded at the regional registries \[[@B1],[@B16]\]. The proposed approach here is substantially different from the previous estimates and, although broader cause of death to estimate cancer envelope is still based on cause of death models in some countries, majority of the data sources of cause of death is now vital registration and/or sampling data. The total number of mortality from cancer is not extrapolated by model alone and the survival model was used to estimate the distribution of death by site, not the actual magnitude of cancer mortality in regions where no or little data on detailed cause of death is available. The model estimates were consistent with mortality distribution of vital records and the Globocan 2000 \[[@B7]\]. Therefore, the major source of discrepancy is not the estimated cancer mortality distribution but the overall mortality envelope applied to each region.

The Globocan 2000 estimates are based on either cancer incidence data from cancer registries in the region (with a survival model used to estimate deaths) or on mortality data collected by regional cancer registries or other sources. Both these sources of data are likely to be incomplete and to result in underestimation of cancer deaths. On the other hand, the GBD 2000 starts with data on the level of all-cause mortality, and uses all available data on cause of death and cause of death models where such data is not available, to estimate the distribution of major cause groups, including cancers. For regions with insufficient vital registration such as AFRO and SEARO regions, this process significantly increases the mortality envelope for these two broad cause categories. It is possible that these methods result in an overestimate of total cancer deaths in some regions, and continuos efforts are being made to obtain additional data from these regions in order to check the validity of these estimates, and where appropriate, to improve them.

Although cancer is still a fatal disease in many developing countries\[[@B2]\], there is a growing evidence that cancer survival even in developing countries is continuously improving \[[@B3],[@B4]\]. The present study suggests that in all regions mortality was much higher in males while incidence were almost the same due to relatively good prognosis of breast and cervix cancers compared to common cancers among males such as liver and lung cancers. Due to the differences in survival by region, incidence-to-mortality rate ratios were higher in developed in which increasing disability among cancer survivors is warranted \[[@B17]-[@B19]\]. It is suggested that data on incidence as well as mortality are necessary to understand the magnitude and trends of cancer problems and to evaluate the interventions against cancer in the context of prevention \[[@B1]\]. When setting priorities, interventions against cancers need to be compared with other health interventions which aims at reducing only morbidity \[[@B5],[@B20]\].

GBD 2000 employs a composite measure of disease burden in terms of disability-adjusted life years (DALYs) which consist of years lived with disability (morbidity) and years of life lost (mortality) \[[@B5]\]. As a part of this exercise, we have estimated both mortality and incidence of cancers by site. We will further estimate the years lived with disability to derive cancer burden in DALYs once weights assigned to disabling conditions are revised based on the estimates from the on-going population-based surveys from more than 70 countries \[[@B21]\].

The presents study also suggests that there is a significant variation in the distribution of cancer mortality and incidence by region depending on age and population structure, distribution of risk factors, and opportunity of detection and treatment \[[@B2],[@B22]\]. However, the frequent cancers such as lung, liver and cervical cancers are potentially preventable \[[@B23]\]. For example, Parkin has estimated that there would have been 23% fewer cases of cancers in the developing world in 1990, if infections such as hepatitis B and C virus and human papilloma virus had been prevented \[[@B24]\]. Another estimate suggests that 230,000 deaths (more than 4% of all cancer deaths) from liver cancer could have been avoided with only immunisations against hepatitis B \[[@B13]\]. Smoking was estimated to be responsible for another 20% of all cancer deaths, all of which are preventable \[[@B13]\].

Given a high incidence of cancers which are potentially preventable in both developed and developing countries, the role of primary prevention, early detection as well as treatment should be evaluated more carefully \[[@B2]\]. Cost-effectiveness analysis plays a role for this purpose, which should be generalisable and comparable across various interventions including both currently delivered and potentially feasible ones \[[@B20]\]. Estimating the magnitude of cancer mortality and incidence is a key input for setting research and intervention priorities. Combined with costs of each intervention, mortality and incidence estimates provide a basis for effectiveness calculation in cost-effectiveness analysis of cancer control programmes.

Conclusions
===========

Based on the algorithm to estimate region-specific overall cancer mortality, and site-specific survival, death distributions, and incidence as a part of GBD 2000 study, it is estimated that cancers accounted for over 7 million deaths (13% of total mortality) and more than 10 million new cases occurred world wide in 2000. Cancer mortality and incidence in developing countries already accounted for over 60% and about half of the global total, respectively. Although there was a significant variation in the distribution of cancer mortality and incidence by region, many of the common cancers are potentially preventable. Magnitude of cancer burden estimation by taking into account both mortality and morbidity is an essential information to set research priorities and policy formulation and can be used for setting cancer control priorities when combined with data on costs of interventions.
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